16.35Open16.35Pre Close0 Volume3 Open Interest57.00Strike Price0.00Turnover105.38%IV0.71%PremiumNov 29, 2024Expiry Date15.83Intrinsic Value100Multiplier4DDays to Expiry0.52Extrinsic Value100Contract SizeAmericanOptions Type0.9864Delta0.0042Gamma4.58Leverage Ratio-0.0331Theta0.0066Rho4.52Eff Leverage0.0027Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet